Commission Directive 2004/33/ECShow full title

Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components (Text with EEA relevance)

1.THE BLOOD COMPONENTSU.K.

1. Red cell preparations
The components listed in points 1.1 to 1.8 may be further processed within blood establishments and must be labelled accordingly
1.1Red cells
1.2Red cells, buffy coat removed
1.3Red cells, leucocyte-depleted
1.4Red cells, in additive solution
1.5Red cells, buffy coat removed, in additive solution
1.6Red cells, leucocyte-depleted, in additive solution
1.7Red cells, apheresis
1.8Whole blood
2. Platelet preparations
The components listed in points 2.1 to 2.6 may be further processed within blood establishments and must be labelled accordingly
2.1Platelets, apheresis
2.2Platelets, apheresis, leucocyte-depleted
2.3Platelets, recovered, pooled
2.4Platelets, recovered, pooled, leucocyte-depleted
2.5Platelets, recovered, single unit
2.6Platelets, recovered, single unit, leucocyte-depleted
3. Plasma preparations
The components listed in 3.1 to 3.3 may be further processed within blood establishments and must be labelled accordingly.
3.1Fresh-frozen plasma
3.2Fresh-frozen plasma, cryoprecipitate-depleted
3.3Cryoprecipitate
4.Granulocytes, apheresis
5. New components
Quality and safety requirements for new blood components must be regulated by the competent national authority. Such new components must be notified to the European Commission with a view to Community action